Standard Operating Procedure for Maintaining a Regulatory Guidance Library
| Department | Regulatory Affairs |
| SOP No. | RA/2026/641 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 09/04/2026 |
| Effective Date | 09/04/2026 |
| Review Date | 09/04/2028 |
Purpose
This Standard Operating Procedure (SOP) establishes a structured and controlled process for maintaining a comprehensive regulatory guidance library that supports ongoing compliance with applicable laws, regulations, and industry standards. The objective is to ensure that all regulatory updates, guidance documents, and policy changes are systematically collected, reviewed, documented, and made accessible to relevant personnel, thereby facilitating informed decision-making, accurate regulatory submissions, and audit readiness across the organization.
Scope
This SOP applies to the Regulatory Affairs department responsible for regulatory intelligence gathering and policy monitoring activities. It encompasses the collection, review, classification, storage, updating, dissemination, and archival of regulatory guidance documents pertaining to all pharmaceutical products, dosage forms, manufacturing processes, quality systems, compliance requirements, and relevant international regulatory authorities. The SOP excludes company proprietary documents unrelated to external regulatory guidance and actions outside the maintenance of the regulatory library.
Responsibilities
- Regulatory Affairs Associates: Collect, review, and file new regulatory guidance documents; update the library database; circulate relevant updates to stakeholders.
- Regulatory Affairs Supervisor: Review and approve inclusion of new guidance into the library; ensure accuracy and completeness.
- Document Control Team: Manage physical and electronic library storage systems ensuring controlled access and version control.
- Quality Assurance (QA): Periodically audit the regulatory guidance library for compliance and completeness.
Accountability
The Head of Regulatory Affairs is accountable for ensuring full compliance with this SOP. This includes oversight of implementation, enforcing adherence, coordinating periodic reviews, addressing escalations, and evaluating the overall effectiveness of the regulatory guidance library maintenance process.
Procedure
1. Preparation and Prerequisites: Regulatory Affairs personnel shall maintain up-to-date subscriptions and alerts from recognized regulatory authorities such as FDA, EMA, ICH, WHO, and other relevant bodies. Access to electronic platforms and physical publications must be secured and documented.
2. Receipt and Initial Review: Upon receiving new or updated guidance documents, Regulatory Affairs Associates shall verify the document’s authenticity and relevance. Documents shall be categorized by region, regulation type, and application area.
3. Verification and Assessment: The Regulatory Affairs Supervisor shall evaluate the impact of new guidance on current operations and existing documentation. If required, cross-functional consultation with Quality, Manufacturing, or Compliance teams shall be arranged for detailed assessment.
4. Documentation and Indexing: Validated documents shall be uniquely indexed and logged into the Regulatory Guidance Library database. Metadata fields shall include document title, identification number, issuing authority, effective date, summary of changes, and applicability.
5. Storage and Access Control: Physical documents shall be stored under controlled conditions ensuring integrity and retrievability. Electronic copies will be saved on secured servers with controlled read/write permissions. Only authorized personnel shall have access to the library.
6. Communication and Distribution: Summaries and critical updates shall be communicated to relevant departments via email notifications, newsletters, or internal platforms within five (5) business days of receipt.
7. Periodic Review and Updates: The regulatory guidance library will be reviewed at least annually to confirm currency. Obsolete or superseded documents shall be clearly marked and archived appropriately.
8. Deviation Management: Any discrepancies or delays in updating the regulatory guidance library shall be documented and escalated to the Head of Regulatory Affairs for immediate corrective action following deviation procedures.
9. Record Retention and Audit Readiness: All entries, review records, communications, and validation documents pertaining to the regulatory guidance library shall be retained as per defined document retention policies and must be readily accessible for internal and external audits.
10. SOP Review and Continuous Improvement: This SOP and the associated library maintenance process shall be reviewed biennially or as regulatory requirements evolve to ensure continuous compliance and operational efficiency.
Abbreviations
- FDA: Food and Drug Administration
- EMA: European Medicines Agency
- ICH: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
- QA: Quality Assurance
- SOP: Standard Operating Procedure
- WHO: World Health Organization
Documents
The following documents are required for the effective maintenance of the regulatory guidance library:
- Regulatory Guidance Receipt and Review Log (Annexure-1)
- Regulatory Guidance Library Index and Summary Sheet (Annexure-2)
- Regulatory Guidance Communication Record (Annexure-3)
References
- ICH Q10 Pharmaceutical Quality System
- FDA 21 CFR Part 11 – Electronic Records; Electronic Signatures
- EMA Guideline on Good Pharmacovigilance Practices (GVP)
- WHO Guidelines on Good Manufacturing Practices
- Internal Document Control and Retention Policies
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Regulatory Guidance Receipt and Review Log
Purpose: To document receipt, initial review, and categorization of new or updated regulatory guidance documents to ensure traceability and proper evaluation.
| Field | Description / Sample Data |
|---|---|
| Date of Receipt | 01/04/2026 |
| Document Title | FDA Guidance on Container Closure Systems |
| Issuing Authority | FDA |
| Document Number/ID | FDA-GCS-202604 |
| Version/Revision Date | 15/03/2026 |
| Initial Reviewer | Regulatory Affairs Associate |
| Relevance/Applicability | Applicable to packaging department and QA |
| Category | Packaging and Labeling |
| Comments/Notes | Requires update to procedures for container qualification |
Annexure-2: Regulatory Guidance Library Index and Summary Sheet
Purpose: To provide a comprehensive index of all regulatory guidance documents maintained in the library, including summary of changes and applicability for efficient retrieval and reference.
| Field | Description / Sample Data |
|---|---|
| Reference Number | RA-LIB-0001 |
| Document Title | FDA Guidance on Container Closure Systems |
| Issuing Authority | FDA |
| Issue Date | 15/03/2026 |
| Summary of Key Changes | Clarification on container qualification protocols |
| Applicable Departments | Packaging, QA, Manufacturing |
| Status | Active |
| Location (Physical / Electronic) | Server: \\RegAffairs\RegGuidance\FDA2026 |
Annexure-3: Regulatory Guidance Communication Record
Purpose: To document the communication of new or updated regulatory guidance to relevant stakeholders to ensure timely awareness and compliance actions.
| Field | Description / Sample Data |
|---|---|
| Date of Communication | 07/04/2026 |
| Document Title | FDA Guidance on Container Closure Systems |
| Recipients | Packaging, QA, Manufacturing, Regulatory Affairs Teams |
| Method of Communication | Email Newsletter |
| Summary of Communication | Key updates shared with emphasis on container qualification changes; requested departments to review SOPs accordingly |
| Follow-up Actions | Packaging assigned to revise SOPs by 30/04/2026 |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 09/04/2026 | 1.0 | Initial issue | New SOP creation |